article

The 8th Congress of the French Neuroscience Society

Posted: 27 March 2007 | | No comments yet

The 8th Congress of the French Neuroscience Society will be held in Montpellier, France on May 22-25, 2007. For the first time, the meeting is organised together with another neuroscience society, the Spanish Neuroscience Society.

The 8th Congress of the French Neuroscience Society will be held in Montpellier, France on May 22-25, 2007. For the first time, the meeting is organised together with another neuroscience society, the Spanish Neuroscience Society.

Date: May 22-25, 2007
Location: Montpellier, France
Website: www.neurosciences.asso.fr

Brain briefings

The 8th Congress of the French Neuroscience Society will be held in Montpellier, France on May 22-25, 2007. For the first time, the meeting is organised together with another neuroscience society, the Spanish Neuroscience Society.

Another novelty this year

In addition to the exhibits, the 8th Congress will provide a unique opportunity to scientists, clinical researchers and decision-makers of the biotechnology world to meet and to exchange views on subjects of common interest in the field of neuroscience research.

Space has been provided to biotechnology companies to present their activities and know-how to researchers. A round table is organised on themes such a how to create a company, how to increase its value and on the subject of public-private relationships.

Programme

Symposia

Wednesday, May 23

10:30-12:30

  • Gruart A. (Sevilla, Spain)
    Closing the gap between learning and synaptic potentiation
  • Barco A. (San Juan de Alicante, Spain)
    Closing the gap between genes and memory: Control of synaptic plasticity and neuronal survival by CREB
  • Landry M. (Bordeaux , France)
    Closing the gap between intrinsic neuronal properties and pain
  • Champagnat J. (Gif Sur Yvette, France)
    Closing the gap between neural tube patterning and emergence of the respiratory control
  • Vidal P.P. (Paris, France)
    Closing the gap between intrinsic neuronal properties and motor control
  • Millan M.J. (Croissy Sur Seine, France)
    Beyond ‘Genomics’: Multi-target strategies for improving the treatment of depressed states
  • Jockers R. (Paris , France)
    Towards the function of the orphan GPR50 receptor, genetically associated with major depressive disorders
  • Marin P. (Montpellier , France)
    Modulation of the functional activity of antidepressant targets by interacting protein networks
  • Vaugeois J.M. (Rouen , France)
    A genetic mouse model of depression to search for novel therapeutical targets
  • Trovero F. (Orleans , France)
    Specific preclinical models for in vivo validation of novel antidepressants
  • Mallat M. (Paris, France)
    Roles of system xc- and NADPH oxidases in neurotoxic activation of microglia
  • Bessis A. (Paris, France)
    Control of synaptic functions by microglial cells
  • Topilko P. (Paris , France)
    PNS stem cells: The boundary cap cells
  • Bovolenta P. (Madrid, Spain)
    Identification of a Six6 regulatory element, a potentially useful factor in the balance between proliferation and differentiation of vertebrate retinal progenitor cells
  • Spassky N. (Paris, France)
    Ependymal differentiation of neural stem cells
  • Ruiz I Altaba A. (Geneva, Switzerland)
    Hedgehog-Gli signaling in neural stem cells and brain tumours
  • Bontempi B. (Talence, France)
    Dynamics of hippocampal-cortical interactions during memory consolidation
  • Dupont S. (Paris, France)
    Human memory: lessons from imaging and epilepsy

Wednesday, May 23

13:00-15:00

  • Buée L. (Lille, France)
    APP-Tau, molecular actors in a complex pathology
  • Maurage C.A. (Lille, France)
    Recent contribution of neuropathology to understand the pathophysiology of Alzheimer’s disease
  • Maurice T. (Montpellier, France)
    Re-examination of the mechanism of action of donepezil (Aricept) in an animal model of amyloid toxicity: Neuroprotective role of the sigma-1 receptor
  • Eustache F. (Caen, France)
    Utility of functional neuro-imaging in the physiopathology of Alzheimer’s disease
  • Touchon J. (Montpellier, France)
    Treatments for Alzheimer’s disease: Reality and perspectives

Thursday, May 24

10:30-12:30

  • Boulin T. (Paris , France)
    Novel membrane proteins modulating cholinergic signaling at the C. elegans neuromuscular junction.
  • Venero C. (Madrid , France)
    Role of NCAM and L1 in learning and memory.
  • Briault S. (Orleans , France)
    A mutation in the neuroligin 4 gene is involved in X-linked mental retardation and autism.
  • Rouyer F. (Gif Sur Yvette , France)
    Control of the morning and evening activity peaks by the multi-oscillators clock of the drosophila brain
  • Saudou F. (Orsay , France)
    Function and dysfunction of huntingtin in the control of cellular dynamics
  • Birman S. (Marseille, France)
    Drosophila models of Huntington’s disease and DRPLA
  • Trottier Y. (Illkirch , France)
    Gene deregulation caused by polyglutamine expansion leads to the loss of neuronal identity
  • Néri C. (Paris , France)
    Modeling polyglutamine neurotoxicity in the nematode Caenorhabditis elegans
  • Fernández-Ruiz J.J. (Madrid , Spain)
    Neuroprotective potential of cannabinoids in Huntington’s disease
  • Bernacer-Maria J. (Pamplona , Spain)
    Distribution of local circuit neurons in the human striatum
  • Mallet N. (Oxford , UK)
    Control of striatal projection neurons by GABAergic fast spiking interneurons in the rat striatum
  • Ravel S. (Bethesda , USA)
    Influence of learning on behavior-related neuronal activity in the primate striatum
  • Faure A. (Orsay , France)
    Nigrostriatal system and procedural memory
  • Redoute J. (Bron , France)
    Brain imaging studies comparing the neural structures involved in processing rewards of different nature in humans
  • Attal N. (Boulogne-Billancourt, France)
    Clinical aspects of neuropathic pain
  • Taylor C. (Ann Harbor, USA)
    Pregabalin and neuropathic pain (the CaVa2dl R237A knock-in mouse model)
  • Snutch T. (Vancouver, Canada)
    Small organic antagonists of N-type calcium channels for pain management
  • Ferrer-Montiel A. (Alicante, Spain)
    Structure and pharmacology of the TRPV1 vanilloid receptor

Thursday, May 24

13:00-15:00

  • De Felipe J. (Madrid, France)
    Cajal and the birth of modern neuroscience
  • Ferrer I. (Barcelona, France)
    Cajal’s degeneration studies
  • Sotelo C. (Paris, France)
    Cajal and the regeneration of the nervous system
  • Barbara J.G. (Paris, France)
    Ranvier, Cajal and the French reception of the neurone doctrine
  • Piccolino M. (Ferrara, Italy)
    Cajal and the retina: “El más antiguo y pertinaz de mi amor de laboratorio”

Friday, May 25

10:30-12:30

  • Isingrini M. (Tours, France)
    Age differences in episodic memory encoding: role of executive functions
  • Lemaire P. (Marseille, France)
    Neural bases of adults’age-related differences in numerosity estimation
  • Lehericy S. (Paris, France)
    Structural and diffusion imaging in the study of normal aging
  • Desgranges B. (Caen, France)
    Neural Bases of Age-related differences in memory performances: a FDG-PET study
  • Naranjo J. (Madrid, Spain)
    DREAM, a Ca-regulated transcriptional repressor, controls viability of cerebellar neurons
  • Charnay P. (Paris, France)
    Molecular control of hindbrain patterning
  • Goridis C. (Paris, France)
    The role of Phox2 transcription factors in hindbrain development and evolution
  • Guillemot F. (London, UK)
    Characterisation of the neurogenic programme activated by proneural transcription factors in neural stem cells
  • Marin O. (Sant Joan d’Alacant, Spain)
    Cellular and molecular mechanisms controlling the development of cortical interneurons
  • Schachner M. (Hamburg, Germany)
    Neuroglial interaction at the synapse: a role for recognition molecules
  • Soriano E. (Barcelona, Spain)
    Molecular mechanisms underlying reelin-dependent neuronal migration
  • Cremer H. (Marseille, France)
    Function of Reelin as a regulator of tangential chain-migration during postnatal neurogenesis
  • Hoareau C. (Bruxelles, Belgium)
    APP and reelin signalling pathway
  • Carmeliet P. (Louvain, Belgium)
    Vascular growth factors and neurodegenerative pathologies

Friday, May 25

13:00-15:00

  • Giraudon P. (Lyon, France)
    Neuroinflammation, a potential for dialogue between the immune and nervous systems
  • Marty S. (Paris, France)
    Tomographic analysis of synaptic ultrastructure without fixative
  • Supplisson S. (Paris, France)
    How glycine transporters shape inhibitory transmission
  • El Mestikawy S. (Creteil, France)
    Heterogeneity of glutamatergic systems in the normal and pathological brain.